ETF Holdings Breakdown of ZLAB

ZLAB institutional holdings

The following institutional investment holdings of ZLAB have been identified

Date	ETF ISIN/Name	Num Shares	Book value	Derived Price per Share	Comment
2025-11-11	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	30,701	USD 675,422 0.5%	22.00
2025-11-11	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	30,701	USD 675,422 0.5%	22.00
Total =		61,402	USD 1,350,844

Book value of shares is calculated on the adjusted close price of each day (row).

News associated with ZLAB

Analysts Set Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) PT at $56.35

Shares of Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the seven ratings firms that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the company. […] - 2025-09-18 05:07:33

Notable Two Hundred Day Moving Average Cross - ZLAB

In trading on Thursday, shares of Zai Lab Ltd (Symbol: ZLAB) crossed below their 200 day moving average of $31.85, changing hands as low as $31.79 per share. Zai Lab Ltd shares are currently trading off about 1.5% on the day. The chart below shows the one year performance of Z - 2025-08-28 12:29:12

Zai Lab (NASDAQ:ZLAB) Now Covered by Jefferies Financial Group

Jefferies Financial Group initiated coverage on shares of Zai Lab (NASDAQ:ZLAB – Free Report) in a research report sent to investors on Monday. The brokerage issued a buy rating and a $52.00 price target on the stock. ZLAB has been the topic of a number of other reports. Citigroup restated a “buy” rating and set […] - 2025-08-26 03:04:48

Zai Lab (NASDAQ:ZLAB) Trading Down 5.9% on Insider Selling

Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB – Get Free Report)’s share price traded down 5.9% during trading on Wednesday following insider selling activity. The company traded as low as $33.49 and last traded at $33.37. 309,987 shares changed hands during trading, a decline of 68% from the average session volume of 971,897 shares. The stock […] - 2025-08-22 02:00:52

US Bancorp DE Has $664,000 Stake in Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB)

US Bancorp DE lifted its stake in shares of Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB – Free Report) by 213.1% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 18,365 shares of the company’s stock after buying an additional 12,500 shares during […] - 2025-08-11 05:24:58

Analysts Set Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Target Price at $54.28

Shares of Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB – Get Free Report) have earned a consensus rating of “Moderate Buy” from the five analysts that are currently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average twelve-month […] - 2025-07-28 02:15:01

Envestnet Asset Management Inc. Acquires 141,436 Shares of Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB)

Envestnet Asset Management Inc. boosted its holdings in shares of Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB – Free Report) by 379.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 178,714 shares of the company’s stock after purchasing an additional 141,436 […] - 2025-07-24 04:26:57

Kingsview Wealth Management LLC Grows Stake in Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB)

Kingsview Wealth Management LLC raised its stake in Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB – Free Report) by 6.0% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,323 shares of the company’s stock after acquiring an additional 529 shares […] - 2025-07-23 06:09:01

Zai Lab (NASDAQ:ZLAB) Shares Gap Down – Time to Sell?

Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB – Get Free Report) shares gapped down before the market opened on Friday . The stock had previously closed at $36.01, but opened at $35.15. Zai Lab shares last traded at $34.59, with a volume of 89,278 shares traded. Analysts Set New Price Targets Several research firms have commented […] - 2025-07-20 05:23:02

Analysts Set Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Price Target at $54.28

Shares of Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB – Get Free Report) have earned a consensus rating of “Moderate Buy” from the five brokerages that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The […] - 2025-07-03 02:21:01

Leerink Partners Boosts Zai Lab (NASDAQ:ZLAB) Price Target to $75.00

Zai Lab (NASDAQ:ZLAB – Get Free Report) had its target price hoisted by stock analysts at Leerink Partners from $73.00 to $75.00 in a research note issued on Monday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Leerink Partners’ target price would indicate a potential upside of 113.25% from the company’s previous […] - 2025-07-02 02:20:52

Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) CEO Sells $855,160.97 in Stock

Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB – Get Free Report) CEO Ying Du sold 23,669 shares of the company’s stock in a transaction dated Thursday, June 26th. The shares were sold at an average price of $36.13, for a total value of $855,160.97. Following the sale, the chief executive officer now owns 514,982 shares in […] - 2025-06-30 05:09:07

Public Employees Retirement System of Ohio Has $484,000 Stock Position in Zai Lab Limited (NASDAQ:ZLAB)

Public Employees Retirement System of Ohio lifted its position in shares of Zai Lab Limited (NASDAQ:ZLAB – Free Report) by 20.8% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 18,480 shares of the company’s stock after buying an additional 3,179 shares during the quarter. Public Employees […] - 2025-06-05 06:14:51

Two Sigma Advisers LP Buys 4,200 Shares of Zai Lab Limited (NASDAQ:ZLAB)

Two Sigma Advisers LP lifted its stake in shares of Zai Lab Limited (NASDAQ:ZLAB – Free Report) by 30.0% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 18,200 shares of the company’s stock after buying an additional 4,200 shares during the period. Two Sigma Advisers LP’s holdings in Zai Lab were worth […] - 2025-06-05 05:14:53

Balyasny Asset Management L.P. Sells 233,103 Shares of Zai Lab Limited (NASDAQ:ZLAB)

Balyasny Asset Management L.P. reduced its stake in shares of Zai Lab Limited (NASDAQ:ZLAB – Free Report) by 90.8% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 23,508 shares of the company’s stock after selling 233,103 shares during the period. Balyasny […] - 2025-05-16 05:34:59

Hsbc Holdings PLC Purchases New Holdings in Zai Lab Limited (NASDAQ:ZLAB)

Hsbc Holdings PLC acquired a new position in Zai Lab Limited (NASDAQ:ZLAB – Free Report) during the fourth quarter, Holdings Channel.com reports. The institutional investor acquired 18,840 shares of the company’s stock, valued at approximately $493,000. Several other institutional investors have also added to or reduced their stakes in ZLAB. Geode Capital Management LLC raised […] - 2025-05-07 04:56:55

Envestnet Asset Management Inc. Invests $976,000 in Zai Lab Limited (NASDAQ:ZLAB)

Envestnet Asset Management Inc. bought a new position in shares of Zai Lab Limited (NASDAQ:ZLAB – Free Report) during the fourth quarter, Holdings Channel reports. The fund bought 37,278 shares of the company’s stock, valued at approximately $976,000. Several other hedge funds have also made changes to their positions in ZLAB. Pictet Asset Management Holding […] - 2025-05-02 04:15:08

Wells Fargo & Company MN Acquires 40,454 Shares of Zai Lab Limited (NASDAQ:ZLAB)

Wells Fargo & Company MN boosted its holdings in shares of Zai Lab Limited (NASDAQ:ZLAB – Free Report) by 8,090.8% in the fourth quarter, HoldingsChannel reports. The fund owned 40,954 shares of the company’s stock after acquiring an additional 40,454 shares during the period. Wells Fargo & Company MN’s holdings in Zai Lab were worth […] - 2025-04-30 04:41:02

Bank of Montreal Can Has $442,000 Stock Position in Zai Lab Limited (NASDAQ:ZLAB)

Bank of Montreal Can boosted its position in shares of Zai Lab Limited (NASDAQ:ZLAB – Free Report) by 21.5% in the 4th quarter, HoldingsChannel.com reports. The firm owned 16,893 shares of the company’s stock after buying an additional 2,993 shares during the quarter. Bank of Montreal Can’s holdings in Zai Lab were worth $442,000 at […] - 2025-04-23 04:56:51

Zai Lab Limited (NASDAQ:ZLAB) Shares Purchased by Fmr LLC

Fmr LLC raised its position in Zai Lab Limited (NASDAQ:ZLAB – Free Report) by 749.1% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 5,475,505 shares of the company’s stock after purchasing an additional 4,830,646 shares during the period. Fmr LLC owned about 5.00% of Zai Lab worth […] - 2025-04-14 06:28:49

Russell Investments Group Ltd. Sells 25,938 Shares of Zai Lab Limited (NASDAQ:ZLAB)

Russell Investments Group Ltd. lessened its position in shares of Zai Lab Limited (NASDAQ:ZLAB – Free Report) by 10.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 231,694 shares of the company’s stock after selling 25,938 shares during the quarter. Russell Investments […] - 2025-04-14 04:54:58

Zai Lab (NASDAQ:ZLAB) Trading Down 7.1% After Insider Selling

Shares of Zai Lab Limited (NASDAQ:ZLAB – Get Free Report) were down 7.1% on Wednesday following insider selling activity. The stock traded as low as $24.74 and last traded at $25.14. Approximately 710,767 shares changed hands during mid-day trading, a decline of 26% from the average daily volume of 966,621 shares. The stock had previously […] - 2025-04-11 02:16:49

63,909 Shares in Zai Lab Limited (NASDAQ:ZLAB) Acquired by Zurcher Kantonalbank Zurich Cantonalbank

Zurcher Kantonalbank Zurich Cantonalbank purchased a new position in shares of Zai Lab Limited (NASDAQ:ZLAB – Free Report) during the fourth quarter, HoldingsChannel reports. The firm purchased 63,909 shares of the company’s stock, valued at approximately $1,674,000. Other institutional investors have also added to or reduced their stakes in the company. Principal Financial Group Inc. […] - 2025-03-18 06:54:52

Cantor Fitzgerald Upgrades Zai Lab (NASDAQ:ZLAB) to “Strong-Buy”

Cantor Fitzgerald upgraded shares of Zai Lab (NASDAQ:ZLAB – Free Report) to a strong-buy rating in a report released on Tuesday,Zacks.com reports. Cantor Fitzgerald also issued estimates for Zai Lab’s FY2025 earnings at ($1.38) EPS. Separately, Bank of America reissued a “neutral” rating and set a $36.10 price objective (up from $29.00) on shares of […] - 2025-03-07 04:30:47

Bank of America Reiterates Neutral Rating for Zai Lab (NASDAQ:ZLAB)

Zai Lab (NASDAQ:ZLAB – Get Free Report)‘s stock had its “neutral” rating reiterated by research analysts at Bank of America in a note issued to investors on Monday, MarketBeat reports. They presently have a $36.10 price objective on the stock, up from their previous price objective of $29.00. Bank of America‘s target price would suggest […] - 2025-03-05 04:33:01

Principal Financial Group Inc. Invests $46.17 Million in Zai Lab Limited (NASDAQ:ZLAB)

Principal Financial Group Inc. acquired a new position in Zai Lab Limited (NASDAQ:ZLAB – Free Report) in the fourth quarter, Holdings Channel.com reports. The institutional investor acquired 1,762,954 shares of the company’s stock, valued at approximately $46,172,000. A number of other institutional investors and hedge funds have also modified their holdings of ZLAB. Y Intercept […] - 2025-02-21 07:49:08

Zai Lab (NASDAQ:ZLAB) Stock Rating Upgraded by Cantor Fitzgerald

Zai Lab (NASDAQ:ZLAB – Get Free Report) was upgraded by stock analysts at Cantor Fitzgerald to a “strong-buy” rating in a report issued on Wednesday,Zacks.com reports. Separately, JPMorgan Chase & Co. increased their price target on Zai Lab from $38.00 to $44.00 and gave the stock an “overweight” rating in a research report on Monday, […] - 2025-02-07 04:28:44

Back to Listing

Disclaimer